Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Gallee

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Prostate|January 1, 1988
Transplantable human prostatic carcinoma (PC-82) in athymic nude mice. III. Effects of estrogens on the growth of the tumor tissueG J van Steenbrugge, M Groen, A van Kreuningen, et al.
The Journal of Urology|November 1, 1989
Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancerM P Gallee, E Visser-de Jong, F J ten Kate, et al.
Journal of the National Cancer Institute|December 1, 1987
Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: potential application for hormone therapy monitoringM P Gallee, G J van Steenbrugge, F J ten Kate, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2001
Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53F Ong, L M Moonen, M P Gallee, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
Cancer|February 1, 1994
Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor controlR C van Doorn, M P Gallee, A A Hart, et al.
Cancer|October 15, 1994
Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancerK N Gaarenstroom, G G Kenter, J M Bonfrer, et al.
Urological Research|January 1, 1990
Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimensM P Gallee, E Visser-de Jong, J A van der Korput, et al.
Gynecologic Oncology|March 1, 1993
HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancerP F van Bommel, A J van den Brule, T J Helmerhorst, et al.
The Prostate|January 1, 1986
Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC-82M P Gallee, C C van Vroonhoven, H A van der Korput, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Prostate|January 1, 1988
Transplantable human prostatic carcinoma (PC-82) in athymic nude mice. III. Effects of estrogens on the growth of the tumor tissueG J van Steenbrugge, M Groen, A van Kreuningen, et al.
The Journal of Urology|November 1, 1989
Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancerM P Gallee, E Visser-de Jong, F J ten Kate, et al.
Journal of the National Cancer Institute|December 1, 1987
Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: potential application for hormone therapy monitoringM P Gallee, G J van Steenbrugge, F J ten Kate, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2001
Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53F Ong, L M Moonen, M P Gallee, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
Cancer|February 1, 1994
Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor controlR C van Doorn, M P Gallee, A A Hart, et al.
Cancer|October 15, 1994
Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancerK N Gaarenstroom, G G Kenter, J M Bonfrer, et al.
Urological Research|January 1, 1990
Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimensM P Gallee, E Visser-de Jong, J A van der Korput, et al.
Gynecologic Oncology|March 1, 1993
HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancerP F van Bommel, A J van den Brule, T J Helmerhorst, et al.
The Prostate|January 1, 1986
Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC-82M P Gallee, C C van Vroonhoven, H A van der Korput, et al.
Pageof 3